LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist A in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset - HMS LINCS Database

LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist A in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20358)

Download: Excel (XLSX), Comma-separated (CSV)

Filter results: >>>>

|<
<<
Previous
Page 46 of 66
Next
>>
>
1126 to 1150 of 1647 records
per page:

Small Molecule	barcode	cell_count	frac_dead	corpse_count	cell_count_dead	row	column	agent	concentration	role	timepoint	replicate	cell_line	dead_count	fraction_dead	cell_count__time0	dead_count__time0	cell_count__ctrl	dead_count__ctrl	fraction_dead__ctrl	increase_fraction_dead	GRvalue
Vorinostat	180619_MC_10	3664	0.0387	84	61	5	5	Vorinostat	0.997999808	treatment	72	2	MCF10A-GM_1	145	0.0381	635.9	71.1	15071	356.7	0.0231	0.01499	0.4674
Vorinostat	180619_MC_10	3916	0.0291	68	48	7	10	Vorinostat	0.997999808	treatment	72	2	MCF10A-GM_2	116	0.0288	635.9	71.1	15071	356.7	0.0231	0.00570	0.4889
Vorinostat	180619_MC_10	4167	0.0300	71	56	8	8	Vorinostat	0.997999808	treatment	72	2	MCF10A-GM_3	127	0.0296	635.9	71.1	15071	356.7	0.0231	0.00650	0.5093
Vorinostat	180619_MC_11	4419	0.0296	69	64	6	20	Vorinostat	0.997999808	treatment	72	2	MCF10A-GM_4	133	0.0292	635.9	71.1	15071	356.7	0.0231	0.00614	0.5288
Vorinostat	180619_MC_11	4494	0.0286	59	71	12	17	Vorinostat	0.997999808	treatment	72	2	MCF10A-GM_5	130	0.0281	635.9	71.1	15071	356.7	0.0231	0.00504	0.5345
Vorinostat	180619_MC_11	4471	0.0250	52	61	14	21	Vorinostat	0.997999808	treatment	72	2	MCF10A-GM_6	113	0.0247	635.9	71.1	15071	356.7	0.0231	0.00158	0.5328
Vorinostat	180619_MC_12	5496	0.0416	151	84	3	9	Vorinostat	0.997999808	treatment	72	2	MCF10A-GM_7	235	0.0410	635.9	71.1	15071	356.7	0.0231	0.01793	0.6036
Vorinostat	180619_MC_12	5046	0.0284	68	77	6	18	Vorinostat	0.997999808	treatment	72	2	MCF10A-GM_8	145	0.0279	635.9	71.1	15071	356.7	0.0231	0.00486	0.5739
Vorinostat	180619_MC_12	5288	0.0237	73	54	10	8	Vorinostat	0.997999808	treatment	72	2	MCF10A-GM_9	127	0.0235	635.9	71.1	15071	356.7	0.0231	0.00038	0.5901
Vorinostat	180619_MC_10	1107	0.0908	83	25	6	20	Vorinostat	3.193598006	treatment	72	2	MCF10A-GM_1	108	0.0889	635.9	71.1	15071	356.7	0.0231	0.06581	0.1291
Vorinostat	180619_MC_10	1141	0.0902	78	32	7	8	Vorinostat	3.193598006	treatment	72	2	MCF10A-GM_2	110	0.0879	635.9	71.1	15071	356.7	0.0231	0.06486	0.1366
Vorinostat	180619_MC_10	774	0.0999	57	26	11	12	Vorinostat	3.193598006	treatment	72	2	MCF10A-GM_3	83	0.0968	635.9	71.1	15071	356.7	0.0231	0.07378	0.0440
Vorinostat	180619_MC_11	1353	0.1031	111	40	7	13	Vorinostat	3.193598006	treatment	72	2	MCF10A-GM_4	151	0.1004	635.9	71.1	15071	356.7	0.0231	0.07732	0.1798
Vorinostat	180619_MC_11	1220	0.1378	144	44	9	11	Vorinostat	3.193598006	treatment	72	2	MCF10A-GM_5	188	0.1335	635.9	71.1	15071	356.7	0.0231	0.11045	0.1534
Vorinostat	180619_MC_11	1382	0.0614	68	21	12	10	Vorinostat	3.193598006	treatment	72	2	MCF10A-GM_6	89	0.0605	635.9	71.1	15071	356.7	0.0231	0.03743	0.1853
Vorinostat	180619_MC_12	1353	0.0968	103	38	6	6	Vorinostat	3.193598006	treatment	72	2	MCF10A-GM_4	141	0.0944	635.9	71.1	15071	356.7	0.0231	0.07130	0.1798
Vorinostat	180619_MC_12	1490	0.1115	143	39	9	17	Vorinostat	3.193598006	treatment	72	2	MCF10A-GM_7	182	0.1089	635.9	71.1	15071	356.7	0.0231	0.08578	0.2050
Vorinostat	180619_MC_12	1597	0.0809	109	29	10	17	Vorinostat	3.193598006	treatment	72	2	MCF10A-GM_8	138	0.0795	635.9	71.1	15071	356.7	0.0231	0.05646	0.2234
Vorinostat	180619_MC_10	796	0.1208	73	32	10	16	Vorinostat	9.98	treatment	72	2	MCF10A-GM_1	105	0.1165	635.9	71.1	15071	356.7	0.0231	0.09346	0.0504
Vorinostat	180619_MC_10	702	0.1395	65	42	11	5	Vorinostat	9.98	treatment	72	2	MCF10A-GM_2	107	0.1323	635.9	71.1	15071	356.7	0.0231	0.10919	0.0219
Vorinostat	180619_MC_10	667	0.1344	62	36	13	5	Vorinostat	9.98	treatment	72	2	MCF10A-GM_3	98	0.1281	635.9	71.1	15071	356.7	0.0231	0.10503	0.0105
Vorinostat	180619_MC_11	897	0.1403	101	39	4	19	Vorinostat	9.98	treatment	72	2	MCF10A-GM_4	140	0.1350	635.9	71.1	15071	356.7	0.0231	0.11193	0.0782
Vorinostat	180619_MC_11	846	0.1688	114	48	5	17	Vorinostat	9.98	treatment	72	2	MCF10A-GM_5	162	0.1607	635.9	71.1	15071	356.7	0.0231	0.13764	0.0645
Vorinostat	180619_MC_11	821	0.1570	109	37	13	13	Vorinostat	9.98	treatment	72	2	MCF10A-GM_6	146	0.1510	635.9	71.1	15071	356.7	0.0231	0.12791	0.0575
Vorinostat	180619_MC_12	586	0.1965	106	30	10	4	Vorinostat	9.98	treatment	72	2	MCF10A-GM_7	136	0.1884	635.9	71.1	15071	356.7	0.0231	0.16529	-0.0177

|<
<<
Previous
Page 46 of 66
Next
>>
>
1126 to 1150 of 1647 records
per page:

HMS LINCS Project

LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist A in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20358)